IFRX InflaRx N.V.
$2.09▲ +1.95%
Healthcare
Other
After hours
$2.09▲ +0.00%
Sep 11, 7:30 PM ET
Volume 334.1K
Avg Volume (10D) 634.6K
Key Metrics & Fundamentals
Market Cap
$308.00M
P/E Ratio
–
Div Yield
–%
52W Range
0.80 - 2.95
% vs 50 MA
4.31%
% vs 200 MA
37.16%
RSI-14
49.3
MACD Histogram
-0.0300
Beta (1Y vs SPY)
2.35
Free Cash Flow
-$2.61M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.14M
COGS
$0
Operating Exp
$7.00M
Operating Income
-$7.00M
EBIT
-$7.00M
Pretax Income
-$10.60M
Net Income
-$10.65M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
InflaRx Announces Participation in September Investor Conferences
GlobeNewswire · Aug 20, 2026 11:30 AM
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
GlobeNewswire · Aug 6, 2026 11:30 AM
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
Zacks · Aug 4, 2026 12:50 PM
InflaRx to Report Second Quarter 2026 Results on August 6, 2026
GlobeNewswire · Jul 30, 2026 11:30 AM
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
GlobeNewswire · Jun 30, 2026 11:30 AM
Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?
Zacks · Jun 26, 2026 9:16 AM
Financial Overview - Income Statement
Quarterly
Sep 2025
See IFRX's money flow as a full page
Social Sentiment
No Reddit posts found for IFRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.